Big Pharma corporations like Pfizer, Novartis, Glaxosmithkline, - as well as over 60% of Fortune 500 multinationals, all maintain entities in Delaware, taking full advantage of ring-fenced legal and financial opacity tools. In addition to banking secrecy and zero disclosure of beneficial owners, Delaware allows for parent companies to establish holding companies within two days, producing nothing, conducting no economic activity in the state, and generally hosting just one shareholder (the parent company). Such entities, allowing the parent company to pay the newly created entity a 'fee' for use of IP, serves as a passive conduit converting taxable income to passive non-taxable profit. The entity's sole purpose is to own and 'manage' laundered income generated from IP.
2More
What is intellectual property (IP/IPR) | E-Commerce Center - 0 views
1More
Primer for Leaders: How to Manage Intellectually Diverse Multi-National Team, by Fidan ... - 0 views
6More
Pambazuka - Intellectual property: Pharmaceuticals, public health and subtle exploitation - 2 views
1More
Innovation in southern Brazil: the case of Paradoxa, by Leonardo Gottems - 0 views
1More
FTSE Curex announce release of executable benchmarks for spot FX - 0 views
1More
Innovation is the biggest challenge for Brazilian companies, says Embraer founder, by L... - 0 views
1More